Xiangqi Chen
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- RNA Interference and Gene Delivery 3
- Cell death mechanisms and regulation 3
- Oncology 13
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Xiaoqiang Tang (5 shared papers)Xiaofeng Chen (2 shared papers)Sheng Yang (17 shared papers)Yaokun Xia (1 shared paper)Jinghua Chen (1 shared paper)Yan An (1 shared paper)Jianming Lan (1 shared paper)Huanghao Yang (1 shared paper)
- Journals
- Cancer Immunology Immunotherapy (3 papers)Current Pharmaceutical Biotechnology (3 papers)International Immunopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Thrombosis Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiangqi Chen
57 papers receiving 982 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 129
- Molecular Medicine 44
- Geriatrics and Gerontology 25
- Molecular Biology 464
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by Xiangqi Chen
This map shows the geographic impact of Xiangqi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqi Chen more than expected).
Fields of papers citing papers by Xiangqi Chen
This network shows the impact of papers produced by Xiangqi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqi Chen. The network helps show where Xiangqi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangqi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 162 | |
| 2 | 2020 | 137 | |
| 3 | 2015 | 101 | |
| 4 | 2019 | 48 | |
| 5 | 2023 | 39 | |
| 6 | 2012 | 28 | |
| 7 | 2011 | 26 | |
| 8 | 2022 | 26 | |
| 9 | 2011 | 24 | |
| 10 | 2021 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2020 | 22 | |
| 13 | 2015 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2007 | 19 | |
| 16 | 2019 | 19 | |
| 17 | 2023 | 18 | |
| 18 | 2020 | 18 | |
| 19 | 2019 | 16 | |
| 20 | 2021 | 15 |
About Xiangqi Chen
Xiangqi Chen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 60 papers that have together received 993 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA Interference and Gene Delivery (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Mesenchymal stem cell research (3 papers), Cell death mechanisms and regulation (3 papers), Electrocatalysts for Energy Conversion (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (129 citations), Molecular Medicine (44 citations), Geriatrics and Gerontology (25 citations), Molecular Biology (464 citations) and Applied Microbiology and Biotechnology (8 citations). Xiangqi Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoqiang Tang, Xiaofeng Chen, Sheng Yang, Yaokun Xia, Jinghua Chen, Yan An, Jianming Lan, Huanghao Yang, Liangliang Wang and Yun Lei. Their work appears in journals such as Cancer Immunology Immunotherapy, Current Pharmaceutical Biotechnology, International Immunopharmacology, Frontiers in Pharmacology and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.